Accessibility Accessibility icon
CONSULTATION (303) 951-5829
Accent Image
This supplement company thinks you’re an idiot!

This supplement company thinks you’re an idiot!

This supplement company thinks you’re an idiot!

October 2, 2015

883717_10151921513905861_392109913_oA recent article on Dr. Yoni Freedhoff’s blog Weighty Matters exposed the type of pseudoscience that marketers (and especially multi-level marketers) such as Arbonne are practicing to get you to buy their products.  Unlike companies within the medical space which must pass rigorous standards and are scrutinized continuously by the FDA, these companies have little to no oversight and can literally publish anything they want and make any claims that they feel like.  Disgusting?  Yes.  But the sad and simple fact is that it is going on and very little is being done to stop it.

This article talked about a “study” put forth by Arbonne claiming support for their Phytosport line of nutritional supplements.  According to the company and provided in small print, these accolades was culled from,”Data based on consumer perception after a 60 day home-use trial of PhystoSport products by 25 Arbonne Independent Consultants, Arbonne employees, and friends.”  According to Dr. Freedhoff,

“…basically Arbonne, referred to by many as a multi-level marketing scheme, asked its own salespeople, employees and friends about the very products they were trying to sell, and then compiled their answers into really awesome sounding statistics with a tiny disclaimer that they’re hoping no one will read.”  -Dr. Yoni Freedhoff (“Weighty Matters”)

weighty_matters_bannerWow…big shocker that the same people who were selling the products and making money not only on their own sales but also from downline sales were enthusiastic about the products they were selling.  And the sad and simple fact is that they actually think you, the consumer, is dumb enough to skip the fine print and dumb enough to then buy these products based on the hype.

I hope this information was helpful and suggest that you read the fine print for whatever you do and before buying anything.

Thanks again for your continued support.  Please leave us your feedback and any comments, questions, or concerns you have about this article or any other that we have published for you.  Be well!

Visualize your NEW LOOK in 3D NOW

START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Natrelle® Breast Implants are for breast augmentation and revision surgery in women at least 22 years old for silicone-filled implants and women at least 18 years old for saline-filled implants.

You should not get breast implants if you currently have an active infection, untreated breast cancer or precancer, or are pregnant or nursing. Tell your doctor about any conditions you have, any medications you are taking, and any planned cancer treatments. Breast implantation is likely not a one-time surgery.

Having implants removed and not replaced may lead to permanent cosmetic changes of the breasts. Breast implants may affect breastfeeding. Gel implants may rupture without symptoms, so periodic imaging after surgery is recommended.

Key complications are reoperation, implant removal, implant rupture, implant deflation with saline-filled implants, and severe capsular contracture.

Talk to your doctor for more information.

The use of Natrelle® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.

Visualize your
NEW LOOK in 3D NOW!

Start now
START NOW
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.

Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.